| 0 |
INSPIRATORY CAPACITY INCREASED |
1 |
0.5000 |
| 1 |
HANDL SYNDROME |
1 |
0.3333 |
| 2 |
COXIELLA TEST POSITIVE |
1 |
0.2500 |
| 3 |
CERVICAL SPINAL CORD PARALYSIS |
2 |
0.0952 |
| 4 |
CSF CELL COUNT ABNORMAL |
2 |
0.0909 |
| 5 |
ANALGESIC INTERVENTION SUPPORTIVE THERAPY |
1 |
0.0833 |
| 6 |
CSF GLUCOSE ABNORMAL |
2 |
0.0833 |
| 7 |
ADJACENT SEGMENT DEGENERATION |
2 |
0.0800 |
| 8 |
PROGRESSIVE BULBAR PALSY |
2 |
0.0625 |
| 9 |
ANOREXIA AND BULIMIA SYNDROME |
1 |
0.0625 |
| 10 |
ANTIBIOTIC RESISTANT STAPHYLOCOCCUS TEST |
1 |
0.0588 |
| 11 |
POST PROCEDURAL COMPLICATION CIRCULATORY |
1 |
0.0526 |
| 12 |
AMYOTROPHIC LATERAL SCLEROSIS |
92 |
0.0427 |
| 13 |
TONGUE ATROPHY |
2 |
0.0408 |
| 14 |
HAEMORRHAGIC NECROTIC PANCREATITIS |
3 |
0.0400 |
| 15 |
DOPAMINE AGONIST WITHDRAWAL SYNDROME |
2 |
0.0370 |
| 16 |
MOTOR NEURONE DISEASE |
18 |
0.0370 |
| 17 |
ECTOPIC ATRIAL RHYTHM |
1 |
0.0312 |
| 18 |
ANORECTAL VARICES HAEMORRHAGE |
1 |
0.0312 |
| 19 |
HIPPOCAMPAL ATROPHY |
1 |
0.0303 |
| 20 |
MUCOSAL IRRITATION |
1 |
0.0303 |
| 21 |
DISSOCIATIVE FUGUE |
2 |
0.0299 |
| 22 |
MULTIFOCAL MICRONODULAR PNEUMOCYTE HYPERPLASIA |
1 |
0.0294 |
| 23 |
HEREDITARY ATAXIA |
1 |
0.0286 |
| 24 |
CSF RED BLOOD CELL COUNT POSITIVE |
1 |
0.0286 |
| 25 |
ELECTROCARDIOGRAM ST SEGMENT |
1 |
0.0278 |
| 26 |
DURAL TEAR |
2 |
0.0256 |
| 27 |
CATHETER SITE HYPERSENSITIVITY |
1 |
0.0250 |
| 28 |
NASOPHARYNGEAL REFLUX |
1 |
0.0244 |
| 29 |
NEUROPSYCHOLOGICAL TEST ABNORMAL |
1 |
0.0233 |
| 30 |
CSF PROTEIN ABNORMAL |
1 |
0.0217 |
| 31 |
PSEUDOCYST |
7 |
0.0217 |
| 32 |
CSF CELL COUNT INCREASED |
3 |
0.0203 |
| 33 |
ARRHYTHMIA INDUCED CARDIOMYOPATHY |
1 |
0.0189 |
| 34 |
CORNEAL ULCER |
1 |
0.0172 |
| 35 |
HEPATIC INFILTRATION EOSINOPHILIC |
1 |
0.0164 |
| 36 |
CSF WHITE BLOOD CELL COUNT INCREASED |
3 |
0.0157 |
| 37 |
CYSTATIN C INCREASED |
2 |
0.0156 |
| 38 |
ASSISTED SUICIDE |
1 |
0.0143 |
| 39 |
CSF VIRUS IDENTIFIED |
1 |
0.0143 |
| 40 |
FEEDING TUBE COMPLICATION |
4 |
0.0129 |
| 41 |
OVERFLOW DIARRHOEA |
1 |
0.0125 |
| 42 |
PANCREATITIS RELAPSING |
10 |
0.0122 |
| 43 |
NONINFECTIOUS MYELITIS |
1 |
0.0122 |
| 44 |
GASTROSTOMY |
17 |
0.0110 |
| 45 |
ALPHA TUMOUR NECROSIS FACTOR INCREASED |
1 |
0.0108 |
| 46 |
PANCREATIC ENZYME ABNORMALITY |
1 |
0.0098 |
| 47 |
CSF PROTEIN INCREASED |
8 |
0.0097 |
| 48 |
DEPERSONALISATION |
8 |
0.0096 |
| 49 |
GAIT DEVIATION |
1 |
0.0093 |
| 50 |
PRODUCT INTOLERANCE |
2 |
0.0090 |
| 51 |
PSEUDARTHROSIS |
2 |
0.0087 |
| 52 |
PHARYNGEAL HYPOAESTHESIA |
8 |
0.0086 |
| 53 |
BENIGN UTERINE NEOPLASM |
1 |
0.0085 |
| 54 |
NECROTISING OESOPHAGITIS |
4 |
0.0080 |
| 55 |
MENOPAUSAL DISORDER |
1 |
0.0078 |
| 56 |
BREATH SOUNDS |
1 |
0.0073 |
| 57 |
CENTRAL NERVOUS SYSTEM VIRAL INFECTION |
1 |
0.0070 |
| 58 |
PANCREATITIS NECROTISING |
16 |
0.0070 |
| 59 |
CLOSTRIDIUM DIFFICILE TOXIN TEST POSITIVE |
1 |
0.0068 |
| 60 |
PANCREATITIS HAEMORRHAGIC |
3 |
0.0065 |
| 61 |
PNEUMONIA CHLAMYDIAL |
1 |
0.0064 |
| 62 |
KERATITIS BACTERIAL |
1 |
0.0061 |
| 63 |
DYSDIADOCHOKINESIS |
1 |
0.0058 |
| 64 |
HAEMOGLOBINAEMIA |
1 |
0.0058 |
| 65 |
BONE MARROW MYELOGRAM ABNORMAL |
1 |
0.0057 |
| 66 |
MULTIFOCAL MOTOR NEUROPATHY |
1 |
0.0057 |
| 67 |
PORTAL VEIN THROMBOSIS |
18 |
0.0056 |
| 68 |
FEEDING TUBE USER |
2 |
0.0055 |
| 69 |
BACTERIA STOOL IDENTIFIED |
1 |
0.0053 |
| 70 |
GASTROSTOMY TUBE INSERTION |
1 |
0.0052 |
| 71 |
EXCESSIVE GRANULATION TISSUE |
4 |
0.0050 |
| 72 |
PERICARDITIS CONSTRICTIVE |
2 |
0.0047 |
| 73 |
GRIP STRENGTH |
1 |
0.0044 |
| 74 |
PARENTERAL NUTRITION |
1 |
0.0043 |
| 75 |
NECROTISING SOFT TISSUE INFECTION |
1 |
0.0043 |
| 76 |
APPLICATION SITE HYPOAESTHESIA |
1 |
0.0043 |
| 77 |
AMNESTIC DISORDER |
2 |
0.0041 |
| 78 |
PANCREATIC ENZYMES INCREASED |
6 |
0.0041 |
| 79 |
INJECTION SITE STREAKING |
1 |
0.0040 |
| 80 |
PHARYNGEAL PARAESTHESIA |
6 |
0.0038 |
| 81 |
FISTULA REPAIR |
1 |
0.0038 |
| 82 |
CSF PRESSURE INCREASED |
1 |
0.0038 |
| 83 |
LYMPHOCYTE STIMULATION TEST POSITIVE |
3 |
0.0037 |
| 84 |
ELECTROCARDIOGRAM ST SEGMENT ABNORMAL |
3 |
0.0037 |
| 85 |
BULBAR PALSY |
1 |
0.0036 |
| 86 |
GASTROINTESTINAL TUBE INSERTION |
9 |
0.0036 |
| 87 |
FIBRIN DEGRADATION PRODUCTS INCREASED |
1 |
0.0034 |
| 88 |
BLOOD CREATINE DECREASED |
1 |
0.0033 |
| 89 |
PROTEIN DEFICIENCY |
1 |
0.0032 |
| 90 |
BLOOD OSMOLARITY DECREASED |
2 |
0.0032 |
| 91 |
CORNEAL INFILTRATES |
1 |
0.0032 |
| 92 |
BREAST CELLULITIS |
1 |
0.0032 |
| 93 |
STAPHYLOCOCCAL ABSCESS |
2 |
0.0031 |
| 94 |
DEFECT CONDUCTION INTRAVENTRICULAR |
1 |
0.0031 |
| 95 |
INTRACRANIAL HYPOTENSION |
2 |
0.0031 |
| 96 |
DISCONTINUED PRODUCT ADMINISTERED |
1 |
0.0030 |
| 97 |
GENITAL INFECTION |
1 |
0.0030 |
| 98 |
SPUTUM RETENTION |
3 |
0.0030 |
| 99 |
POST CONCUSSION SYNDROME |
1 |
0.0029 |
| 100 |
MARROW HYPERPLASIA |
2 |
0.0029 |
| 101 |
PNEUMONITIS ASPIRATION |
1 |
0.0029 |
| 102 |
POST LUMBAR PUNCTURE SYNDROME |
3 |
0.0029 |
| 103 |
HYPOAESTHESIA ORAL |
43 |
0.0028 |
| 104 |
NEUROMUSCULAR TOXICITY |
1 |
0.0028 |
| 105 |
TONGUE PARALYSIS |
2 |
0.0028 |
| 106 |
OBSESSIVE-COMPULSIVE SYMPTOM |
1 |
0.0027 |
| 107 |
MECHANICAL VENTILATION |
5 |
0.0026 |
| 108 |
PANCREATIC PSEUDOCYST |
2 |
0.0026 |
| 109 |
POVERTY OF SPEECH |
1 |
0.0026 |
| 110 |
DROPPED HEAD SYNDROME |
1 |
0.0025 |
| 111 |
HOUSEBOUND |
1 |
0.0025 |
| 112 |
LUNG DIFFUSION TEST DECREASED |
1 |
0.0025 |
| 113 |
DEPENDENCE ON RESPIRATOR |
1 |
0.0025 |
| 114 |
SKIN BACTERIAL INFECTION |
2 |
0.0025 |
| 115 |
PROCEDURAL HEADACHE |
1 |
0.0024 |
| 116 |
NORMAL PRESSURE HYDROCEPHALUS |
1 |
0.0024 |
| 117 |
QUADRIPARESIS |
4 |
0.0024 |
| 118 |
DYSPHORIA |
12 |
0.0024 |
| 119 |
DEVICE CONNECTION ISSUE |
5 |
0.0024 |
| 120 |
OROPHARYNGEAL SPASM |
1 |
0.0024 |
| 121 |
TONGUE MOVEMENT DISTURBANCE |
2 |
0.0023 |
| 122 |
MUSCLE CONTRACTIONS INVOLUNTARY |
8 |
0.0023 |
| 123 |
BILIARY SEPSIS |
1 |
0.0022 |
| 124 |
CATHETER SITE SWELLING |
2 |
0.0021 |
| 125 |
BLOOD BICARBONATE INCREASED |
1 |
0.0021 |
| 126 |
OPEN FRACTURE |
1 |
0.0021 |
| 127 |
TRAUMATIC LUNG INJURY |
4 |
0.0021 |
| 128 |
DEPENDENCE ON OXYGEN THERAPY |
1 |
0.0020 |
| 129 |
PRODUCT USE COMPLAINT |
31 |
0.0020 |
| 130 |
BONE CANCER METASTATIC |
1 |
0.0019 |
| 131 |
PALMOPLANTAR PUSTULOSIS |
1 |
0.0019 |
| 132 |
BLOOD IMMUNOGLOBULIN A INCREASED |
1 |
0.0019 |
| 133 |
AUTOSCOPY |
1 |
0.0019 |
| 134 |
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION |
19 |
0.0018 |
| 135 |
HYPERAMYLASAEMIA |
1 |
0.0018 |
| 136 |
BLOOD MAGNESIUM ABNORMAL |
1 |
0.0018 |
| 137 |
BLOOD PH INCREASED |
1 |
0.0018 |
| 138 |
LUNG CONSOLIDATION |
5 |
0.0018 |
| 139 |
OEDEMATOUS PANCREATITIS |
1 |
0.0018 |
| 140 |
PARAESTHESIA ORAL |
25 |
0.0017 |
| 141 |
EPIDIDYMITIS |
2 |
0.0017 |
| 142 |
ALLODYNIA |
2 |
0.0017 |
| 143 |
RESTRICTIVE PULMONARY DISEASE |
2 |
0.0017 |
| 144 |
JAUNDICE CHOLESTATIC |
6 |
0.0017 |
| 145 |
ANTEROGRADE AMNESIA |
1 |
0.0017 |
| 146 |
DYSMETRIA |
1 |
0.0017 |
| 147 |
PALATAL DISORDER |
1 |
0.0017 |
| 148 |
PANCREATITIS ACUTE |
37 |
0.0016 |
| 149 |
MYOPATHY TOXIC |
1 |
0.0016 |
| 150 |
MEDICAL DEVICE SITE INFECTION |
1 |
0.0016 |
| 151 |
MUSCLE ABSCESS |
1 |
0.0016 |
| 152 |
WHITE BLOOD CELLS URINE POSITIVE |
3 |
0.0016 |
| 153 |
ACTIVITIES OF DAILY LIVING DECREASED |
1 |
0.0016 |
| 154 |
MENINGITIS ASEPTIC |
7 |
0.0016 |
| 155 |
NEUROPATHIC ARTHROPATHY |
1 |
0.0015 |
| 156 |
COMPUTERISED TOMOGRAM THORAX ABNORMAL |
1 |
0.0015 |
| 157 |
RASH MORBILLIFORM |
4 |
0.0014 |
| 158 |
FOREARM FRACTURE |
1 |
0.0014 |
| 159 |
TRACHEOSTOMY |
2 |
0.0014 |
| 160 |
LYMPHOCYTOSIS |
3 |
0.0014 |
| 161 |
PRODUCT MONITORING ERROR |
2 |
0.0014 |
| 162 |
BLOOD URIC ACID INCREASED |
8 |
0.0014 |
| 163 |
FOREIGN BODY ASPIRATION |
1 |
0.0014 |
| 164 |
CHLAMYDIAL INFECTION |
1 |
0.0013 |
| 165 |
INCREASED VISCOSITY OF UPPER RESPIRATORY SECRETION |
1 |
0.0013 |
| 166 |
PULMONARY ARTERY THROMBOSIS |
1 |
0.0013 |
| 167 |
PORTAL HYPERTENSION |
4 |
0.0013 |
| 168 |
MYELITIS |
2 |
0.0013 |
| 169 |
BILIRUBIN CONJUGATED INCREASED |
3 |
0.0013 |
| 170 |
BLOOD FIBRINOGEN INCREASED |
1 |
0.0013 |
| 171 |
PNEUMONIA MYCOPLASMAL |
1 |
0.0013 |
| 172 |
HEAT EXHAUSTION |
1 |
0.0012 |
| 173 |
COLON CANCER METASTATIC |
2 |
0.0012 |
| 174 |
GLOMERULAR FILTRATION RATE INCREASED |
1 |
0.0012 |
| 175 |
COLLAPSE OF LUNG |
1 |
0.0012 |
| 176 |
TROPONIN I INCREASED |
2 |
0.0012 |
| 177 |
SALIVARY HYPERSECRETION |
12 |
0.0012 |
| 178 |
AMAUROSIS |
1 |
0.0012 |
| 179 |
CEREBRAL VENOUS SINUS THROMBOSIS |
1 |
0.0012 |
| 180 |
CATHETER SITE PRURITUS |
1 |
0.0011 |
| 181 |
RADICULOPATHY |
3 |
0.0011 |
| 182 |
CEREBELLAR ATROPHY |
1 |
0.0011 |
| 183 |
PULMONARY TOXICITY |
8 |
0.0011 |
| 184 |
INTRA-ABDOMINAL FLUID COLLECTION |
2 |
0.0011 |
| 185 |
MENINGIOMA BENIGN |
1 |
0.0011 |
| 186 |
PERONEAL NERVE PALSY |
6 |
0.0011 |
| 187 |
MYELOPATHY |
2 |
0.0011 |
| 188 |
CEREBELLAR ATAXIA |
1 |
0.0010 |
| 189 |
INFUSION SITE NODULE |
1 |
0.0010 |
| 190 |
IDIOSYNCRATIC DRUG REACTION |
1 |
0.0010 |
| 191 |
CORONARY ARTERY THROMBOSIS |
2 |
0.0010 |
| 192 |
BREAST ABSCESS |
1 |
0.0010 |
| 193 |
ALVEOLITIS ALLERGIC |
1 |
0.0010 |
| 194 |
INFUSION SITE DISCOMFORT |
1 |
0.0010 |
| 195 |
PNEUMONIA ASPIRATION |
24 |
0.0010 |
| 196 |
NASAL INFLAMMATION |
1 |
0.0009 |
| 197 |
NEUROMYOPATHY |
1 |
0.0009 |
| 198 |
GALLBLADDER ENLARGEMENT |
1 |
0.0009 |
| 199 |
SPUTUM INCREASED |
2 |
0.0009 |
| 200 |
GASTROINTESTINAL TRACT IRRITATION |
1 |
0.0009 |
| 201 |
PILOERECTION |
1 |
0.0009 |
| 202 |
PULMONARY FUNCTION TEST DECREASED |
4 |
0.0009 |
| 203 |
HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME |
1 |
0.0009 |
| 204 |
CATHETER SITE DISCHARGE |
1 |
0.0009 |
| 205 |
HYPERSENSITIVITY PNEUMONITIS |
1 |
0.0009 |
| 206 |
DISEASE COMPLICATION |
4 |
0.0009 |
| 207 |
PO2 DECREASED |
1 |
0.0009 |
| 208 |
METHAEMOGLOBINAEMIA |
2 |
0.0009 |
| 209 |
HEPATIC CYTOLYSIS |
11 |
0.0009 |
| 210 |
ACUTE LUNG INJURY |
1 |
0.0008 |
| 211 |
CHOLESTASIS |
16 |
0.0008 |
| 212 |
RADIUS FRACTURE |
2 |
0.0008 |
| 213 |
PROSTATIC OPERATION |
1 |
0.0008 |
| 214 |
CHRONIC RESPIRATORY FAILURE |
1 |
0.0008 |
| 215 |
SLOW SPEECH |
2 |
0.0008 |
| 216 |
BLOOD IMMUNOGLOBULIN G INCREASED |
1 |
0.0008 |
| 217 |
OTITIS EXTERNA |
1 |
0.0008 |
| 218 |
DISEASE PROGRESSION |
96 |
0.0008 |
| 219 |
ABDOMINAL TENDERNESS |
4 |
0.0008 |
| 220 |
JOINT WARMTH |
1 |
0.0008 |
| 221 |
SEDATION COMPLICATION |
2 |
0.0008 |
| 222 |
HAEMOLYTIC ANAEMIA |
7 |
0.0008 |
| 223 |
CARDIAC VENTRICULAR THROMBOSIS |
1 |
0.0008 |
| 224 |
BILIARY OBSTRUCTION |
1 |
0.0008 |
| 225 |
PROTEIN TOTAL ABNORMAL |
1 |
0.0008 |
| 226 |
ENCEPHALITIS AUTOIMMUNE |
1 |
0.0008 |
| 227 |
CARDIOACTIVE DRUG LEVEL INCREASED |
1 |
0.0008 |
| 228 |
DEVICE MISUSE |
1 |
0.0008 |
| 229 |
HERPES OPHTHALMIC |
1 |
0.0008 |
| 230 |
BLOOD POTASSIUM ABNORMAL |
2 |
0.0007 |
| 231 |
INTESTINAL DILATATION |
1 |
0.0007 |
| 232 |
INTERSTITIAL LUNG DISEASE |
36 |
0.0007 |
| 233 |
CALCULUS BLADDER |
1 |
0.0007 |
| 234 |
INTESTINAL MASS |
1 |
0.0007 |
| 235 |
ASPIRATION |
8 |
0.0007 |
| 236 |
INFUSION SITE RASH |
1 |
0.0007 |
| 237 |
ACUTE RESPIRATORY FAILURE |
14 |
0.0007 |
| 238 |
RESPIRATION ABNORMAL |
5 |
0.0007 |
| 239 |
CHOKING SENSATION |
4 |
0.0007 |
| 240 |
CHOKING |
14 |
0.0007 |
| 241 |
BRONCHIAL OBSTRUCTION |
1 |
0.0007 |
| 242 |
PERIPHERAL ARTERY OCCLUSION |
1 |
0.0007 |
| 243 |
MYELITIS TRANSVERSE |
1 |
0.0007 |
| 244 |
PRERENAL FAILURE |
1 |
0.0007 |
| 245 |
MUSCLE FATIGUE |
3 |
0.0007 |
| 246 |
ATYPICAL MYCOBACTERIAL INFECTION |
1 |
0.0007 |
| 247 |
RESPIRATORY SYMPTOM |
2 |
0.0007 |
| 248 |
RESPIRATORY FAILURE |
51 |
0.0007 |
| 249 |
OBSTRUCTIVE SLEEP APNOEA SYNDROME |
1 |
0.0007 |
| 250 |
NORMOCYTIC ANAEMIA |
1 |
0.0007 |
| 251 |
BLOOD CREATINE INCREASED |
3 |
0.0007 |
| 252 |
ODYNOPHAGIA |
4 |
0.0007 |
| 253 |
ATYPICAL PNEUMONIA |
2 |
0.0007 |
| 254 |
PEMPHIGOID |
5 |
0.0007 |
| 255 |
EMBOLISM VENOUS |
2 |
0.0007 |
| 256 |
ONYCHOLYSIS |
1 |
0.0006 |
| 257 |
FOREIGN BODY IN THROAT |
2 |
0.0006 |
| 258 |
MUSCULAR WEAKNESS |
71 |
0.0006 |
| 259 |
HYPOVENTILATION |
2 |
0.0006 |
| 260 |
INJECTION SITE INFECTION |
2 |
0.0006 |
| 261 |
HOSPICE CARE |
6 |
0.0006 |
| 262 |
PATHOLOGICAL GAMBLING |
1 |
0.0006 |
| 263 |
GASTRIC DILATATION |
1 |
0.0006 |
| 264 |
ENTEROBACTER INFECTION |
1 |
0.0006 |
| 265 |
POST PROCEDURAL HAEMATOMA |
1 |
0.0006 |
| 266 |
TACHYPNOEA |
8 |
0.0006 |
| 267 |
GAZE PALSY |
1 |
0.0006 |
| 268 |
GLIOBLASTOMA |
1 |
0.0006 |
| 269 |
BLADDER NEOPLASM |
1 |
0.0006 |
| 270 |
MUSCLE RIGIDITY |
7 |
0.0006 |
| 271 |
WOUND COMPLICATION |
2 |
0.0006 |
| 272 |
MILIARIA |
1 |
0.0006 |
| 273 |
TRISMUS |
3 |
0.0006 |
| 274 |
PRODUCT CONTAINER SEAL ISSUE |
1 |
0.0006 |
| 275 |
APLASTIC ANAEMIA |
3 |
0.0006 |
| 276 |
EAR PRURITUS |
2 |
0.0006 |
| 277 |
INFUSION SITE DISCHARGE |
1 |
0.0006 |
| 278 |
DEPRESSIVE SYMPTOM |
2 |
0.0006 |
| 279 |
RETCHING |
12 |
0.0006 |
| 280 |
PARAPARESIS |
1 |
0.0006 |
| 281 |
HEPATIC ENZYME INCREASED |
38 |
0.0006 |
| 282 |
POOR QUALITY SLEEP |
12 |
0.0006 |
| 283 |
PNEUMOMEDIASTINUM |
1 |
0.0006 |
| 284 |
MUSCLE ATROPHY |
7 |
0.0006 |
| 285 |
MYDRIASIS |
7 |
0.0005 |
| 286 |
LOBAR PNEUMONIA |
1 |
0.0005 |
| 287 |
CATHETER SITE INFECTION |
2 |
0.0005 |
| 288 |
LIP DISORDER |
1 |
0.0005 |
| 289 |
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME |
2 |
0.0005 |
| 290 |
HYPOREFLEXIA |
1 |
0.0005 |
| 291 |
CONCOMITANT DISEASE PROGRESSION |
1 |
0.0005 |
| 292 |
DECREASED INTEREST |
3 |
0.0005 |
| 293 |
DIPLEGIA |
1 |
0.0005 |
| 294 |
EMPYEMA |
1 |
0.0005 |
| 295 |
EMPHYSEMA |
5 |
0.0005 |
| 296 |
FOAMING AT MOUTH |
1 |
0.0005 |
| 297 |
CHANGE OF BOWEL HABIT |
1 |
0.0005 |
| 298 |
HYPERBILIRUBINAEMIA |
5 |
0.0005 |
| 299 |
DYSARTHRIA |
18 |
0.0005 |
| 300 |
NEUROGENIC BLADDER |
1 |
0.0005 |
| 301 |
TONGUE DISCOMFORT |
2 |
0.0005 |
| 302 |
POOR PERIPHERAL CIRCULATION |
2 |
0.0005 |
| 303 |
HEPATIC PAIN |
2 |
0.0005 |
| 304 |
CATHETER SITE ERYTHEMA |
1 |
0.0005 |
| 305 |
OCULOGYRIC CRISIS |
1 |
0.0005 |
| 306 |
DYSPHAGIA |
44 |
0.0005 |
| 307 |
PERIODONTITIS |
1 |
0.0005 |
| 308 |
HEPATITIS ACUTE |
3 |
0.0005 |
| 309 |
TONGUE DISCOLOURATION |
2 |
0.0005 |
| 310 |
ELECTROCARDIOGRAM ST SEGMENT DEPRESSION |
1 |
0.0005 |
| 311 |
FAECES PALE |
1 |
0.0004 |
| 312 |
PAPILLOEDEMA |
2 |
0.0004 |
| 313 |
PERIARTHRITIS |
1 |
0.0004 |
| 314 |
DISLOCATION OF VERTEBRA |
1 |
0.0004 |
| 315 |
ENCEPHALITIS |
3 |
0.0004 |
| 316 |
INFUSION SITE INFECTION |
1 |
0.0004 |
| 317 |
MENOPAUSAL SYMPTOMS |
1 |
0.0004 |
| 318 |
COLORECTAL CANCER METASTATIC |
1 |
0.0004 |
| 319 |
INTENTIONAL DOSE OMISSION |
12 |
0.0004 |
| 320 |
ORAL INTAKE REDUCED |
1 |
0.0004 |
| 321 |
BLOOD IMMUNOGLOBULIN E INCREASED |
1 |
0.0004 |
| 322 |
BREATH ODOUR |
1 |
0.0004 |
| 323 |
HAEMATOLOGICAL INFECTION |
1 |
0.0004 |
| 324 |
ENCEPHALOPATHY |
10 |
0.0004 |
| 325 |
ALANINE AMINOTRANSFERASE INCREASED |
25 |
0.0004 |
| 326 |
MUSCLE SPASTICITY |
5 |
0.0004 |
| 327 |
ABDOMINAL DISCOMFORT |
68 |
0.0004 |
| 328 |
MUCOUS STOOLS |
2 |
0.0004 |
| 329 |
RESPIRATORY DISORDER |
12 |
0.0004 |
| 330 |
INCREASED BRONCHIAL SECRETION |
1 |
0.0004 |
| 331 |
INCREASED UPPER AIRWAY SECRETION |
2 |
0.0004 |
| 332 |
UNRESPONSIVE TO STIMULI |
10 |
0.0004 |
| 333 |
CATHETER SITE PAIN |
1 |
0.0004 |
| 334 |
LUNG OPACITY |
1 |
0.0004 |
| 335 |
DEATH |
322 |
0.0004 |
| 336 |
ABDOMINAL MASS |
1 |
0.0004 |
| 337 |
HYPONATRAEMIA |
21 |
0.0004 |
| 338 |
BLOOD SODIUM INCREASED |
1 |
0.0004 |
| 339 |
LIP BLISTER |
1 |
0.0004 |
| 340 |
CLUMSINESS |
1 |
0.0004 |
| 341 |
ABNORMAL FAECES |
3 |
0.0004 |
| 342 |
CLONUS |
1 |
0.0004 |
| 343 |
INTRACRANIAL PRESSURE INCREASED |
2 |
0.0004 |
| 344 |
APHONIA |
5 |
0.0004 |
| 345 |
ENDOTRACHEAL INTUBATION |
1 |
0.0004 |
| 346 |
GENERALISED ERYTHEMA |
2 |
0.0004 |
| 347 |
MICTURITION URGENCY |
4 |
0.0003 |
| 348 |
MYOCARDITIS |
4 |
0.0003 |
| 349 |
PHARYNGEAL DISORDER |
1 |
0.0003 |
| 350 |
MOUTH SWELLING |
2 |
0.0003 |
| 351 |
FINE MOTOR SKILL DYSFUNCTION |
1 |
0.0003 |
| 352 |
DYSPNOEA AT REST |
1 |
0.0003 |
| 353 |
STRESS CARDIOMYOPATHY |
2 |
0.0003 |
| 354 |
AUTONOMIC NERVOUS SYSTEM IMBALANCE |
1 |
0.0003 |
| 355 |
PANCREATITIS |
18 |
0.0003 |
| 356 |
DEPRESSED MOOD |
18 |
0.0003 |
| 357 |
LUNG INFILTRATION |
3 |
0.0003 |
| 358 |
BLOOD TRIGLYCERIDES INCREASED |
6 |
0.0003 |
| 359 |
FLATULENCE |
19 |
0.0003 |
| 360 |
NORMOCHROMIC NORMOCYTIC ANAEMIA |
1 |
0.0003 |
| 361 |
OROPHARYNGEAL DISCOMFORT |
3 |
0.0003 |
| 362 |
CENTRAL VENOUS CATHETERISATION |
1 |
0.0003 |
| 363 |
LIVER FUNCTION TEST INCREASED |
7 |
0.0003 |
| 364 |
DUODENITIS |
1 |
0.0003 |
| 365 |
SPEECH DISORDER |
17 |
0.0003 |
| 366 |
CONCOMITANT DISEASE AGGRAVATED |
2 |
0.0003 |
| 367 |
ADVERSE DRUG REACTION |
29 |
0.0003 |
| 368 |
AGRANULOCYTOSIS |
6 |
0.0003 |
| 369 |
ILEUS |
4 |
0.0003 |
| 370 |
INFUSION SITE EXTRAVASATION |
2 |
0.0003 |
| 371 |
THERAPY PARTIAL RESPONDER |
5 |
0.0003 |
| 372 |
INFUSION SITE PRURITUS |
1 |
0.0003 |
| 373 |
ELECTROENCEPHALOGRAM ABNORMAL |
1 |
0.0003 |
| 374 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
5 |
0.0003 |
| 375 |
ORTHOPNOEA |
1 |
0.0003 |
| 376 |
ATELECTASIS |
3 |
0.0003 |
| 377 |
PARKINSONISM |
3 |
0.0003 |
| 378 |
POSTURE ABNORMAL |
1 |
0.0003 |
| 379 |
REFUSAL OF TREATMENT BY PATIENT |
2 |
0.0003 |
| 380 |
PRODUCT PREPARATION ISSUE |
2 |
0.0003 |
| 381 |
MUSCLE TWITCHING |
7 |
0.0003 |
| 382 |
DYSGRAPHIA |
2 |
0.0003 |
| 383 |
IMMUNOSUPPRESSANT DRUG LEVEL INCREASED |
1 |
0.0003 |
| 384 |
CORONAVIRUS INFECTION |
2 |
0.0003 |
| 385 |
BLADDER DISORDER |
3 |
0.0003 |
| 386 |
MENINGITIS |
2 |
0.0003 |
| 387 |
BRONCHIECTASIS |
2 |
0.0003 |
| 388 |
EUPHORIC MOOD |
3 |
0.0003 |
| 389 |
INITIAL INSOMNIA |
3 |
0.0003 |
| 390 |
NEPHROTIC SYNDROME |
2 |
0.0003 |
| 391 |
POOR VENOUS ACCESS |
3 |
0.0003 |
| 392 |
RESPIRATORY DISTRESS |
8 |
0.0003 |
| 393 |
DROOLING |
2 |
0.0003 |
| 394 |
BLOOD CREATININE ABNORMAL |
1 |
0.0003 |
| 395 |
HYPOPNOEA |
1 |
0.0003 |
| 396 |
ORAL DISCOMFORT |
4 |
0.0003 |
| 397 |
DEVICE OCCLUSION |
4 |
0.0003 |
| 398 |
INCONTINENCE |
3 |
0.0003 |
| 399 |
NECROTISING FASCIITIS |
1 |
0.0003 |
| 400 |
ASPARTATE AMINOTRANSFERASE INCREASED |
15 |
0.0003 |
| 401 |
HAEMORRHAGE SUBCUTANEOUS |
1 |
0.0003 |
| 402 |
PRODUCT SUPPLY ISSUE |
2 |
0.0003 |
| 403 |
DERMATITIS BULLOUS |
2 |
0.0003 |
| 404 |
HYPOKINESIA |
4 |
0.0003 |
| 405 |
GASTROENTERITIS |
4 |
0.0003 |
| 406 |
MALNUTRITION |
3 |
0.0003 |
| 407 |
IMPULSIVE BEHAVIOUR |
1 |
0.0003 |
| 408 |
HEPATIC NECROSIS |
1 |
0.0003 |
| 409 |
FACE INJURY |
1 |
0.0003 |
| 410 |
COMMUNICATION DISORDER |
1 |
0.0003 |
| 411 |
LIPASE INCREASED |
2 |
0.0003 |
| 412 |
HYPOXIA |
9 |
0.0003 |
| 413 |
OESOPHAGEAL PAIN |
1 |
0.0003 |
| 414 |
PATENT DUCTUS ARTERIOSUS |
1 |
0.0003 |
| 415 |
HYPERPHAGIA |
1 |
0.0003 |
| 416 |
AZOTAEMIA |
1 |
0.0003 |
| 417 |
MYASTHENIA GRAVIS |
2 |
0.0002 |
| 418 |
FRUSTRATION TOLERANCE DECREASED |
2 |
0.0002 |
| 419 |
TASTE DISORDER |
5 |
0.0002 |
| 420 |
DECUBITUS ULCER |
2 |
0.0002 |
| 421 |
THERAPEUTIC RESPONSE UNEXPECTED |
11 |
0.0002 |
| 422 |
ASPHYXIA |
2 |
0.0002 |
| 423 |
GOITRE |
1 |
0.0002 |
| 424 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
6 |
0.0002 |
| 425 |
ACCIDENTAL EXPOSURE |
1 |
0.0002 |
| 426 |
SECRETION DISCHARGE |
3 |
0.0002 |
| 427 |
CANDIDA INFECTION |
4 |
0.0002 |
| 428 |
LIP OEDEMA |
1 |
0.0002 |
| 429 |
INCORRECT DRUG ADMINISTRATION RATE |
1 |
0.0002 |
| 430 |
HYPOPHAGIA |
6 |
0.0002 |
| 431 |
FACIAL PARALYSIS |
2 |
0.0002 |
| 432 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
4 |
0.0002 |
| 433 |
BALANCE DISORDER |
20 |
0.0002 |
| 434 |
HEPATIC LESION |
1 |
0.0002 |
| 435 |
OCULAR ICTERUS |
1 |
0.0002 |
| 436 |
MONOPLEGIA |
1 |
0.0002 |
| 437 |
ABDOMINAL PAIN UPPER |
47 |
0.0002 |
| 438 |
EOSINOPHILIA |
4 |
0.0002 |
| 439 |
HAEMORRHAGIC ANAEMIA |
1 |
0.0002 |
| 440 |
GRIP STRENGTH DECREASED |
2 |
0.0002 |
| 441 |
ABDOMINAL ABSCESS |
1 |
0.0002 |
| 442 |
LIMB DISCOMFORT |
7 |
0.0002 |
| 443 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
4 |
0.0002 |
| 444 |
TRANSAMINASES INCREASED |
5 |
0.0002 |
| 445 |
ANAL INCONTINENCE |
2 |
0.0002 |
| 446 |
PRODUCT TASTE ABNORMAL |
3 |
0.0002 |
| 447 |
PULMONARY EMBOLISM |
21 |
0.0002 |
| 448 |
HAEMOGLOBIN INCREASED |
1 |
0.0002 |
| 449 |
IMMUNE THROMBOCYTOPENIA |
1 |
0.0002 |
| 450 |
EAR DISORDER |
1 |
0.0002 |
| 451 |
ASTHENIA |
82 |
0.0002 |
| 452 |
CHRONIC MYELOID LEUKAEMIA |
1 |
0.0002 |
| 453 |
COORDINATION ABNORMAL |
3 |
0.0002 |
| 454 |
DIARRHOEA |
138 |
0.0002 |
| 455 |
SINUS TACHYCARDIA |
3 |
0.0002 |
| 456 |
CHRONIC LYMPHOCYTIC LEUKAEMIA |
1 |
0.0002 |
| 457 |
LOWER LIMB FRACTURE |
4 |
0.0002 |
| 458 |
GUILLAIN-BARRE SYNDROME |
1 |
0.0002 |
| 459 |
DYSPHONIA |
12 |
0.0002 |
| 460 |
GASTROINTESTINAL DISORDER |
18 |
0.0002 |
| 461 |
HAEMORRHAGE INTRACRANIAL |
3 |
0.0002 |
| 462 |
GAIT DISTURBANCE |
38 |
0.0002 |
| 463 |
PRODUCT SOLUBILITY ABNORMAL |
1 |
0.0002 |
| 464 |
CORONARY ARTERIAL STENT INSERTION |
1 |
0.0002 |
| 465 |
NAUSEA |
156 |
0.0002 |
| 466 |
PATHOLOGICAL FRACTURE |
1 |
0.0002 |
| 467 |
OXYGEN SATURATION DECREASED |
11 |
0.0002 |
| 468 |
PHLEBITIS |
1 |
0.0002 |
| 469 |
DEVICE RELATED INFECTION |
3 |
0.0002 |
| 470 |
THERAPY CESSATION |
10 |
0.0002 |
| 471 |
FAILURE TO THRIVE |
1 |
0.0002 |
| 472 |
POOR QUALITY PRODUCT ADMINISTERED |
2 |
0.0002 |
| 473 |
HEAD INJURY |
6 |
0.0002 |
| 474 |
PNEUMOTHORAX |
3 |
0.0002 |
| 475 |
HEPATIC FUNCTION ABNORMAL |
7 |
0.0002 |
| 476 |
JAUNDICE |
5 |
0.0002 |
| 477 |
ANAL ABSCESS |
1 |
0.0002 |
| 478 |
BEHAVIOUR DISORDER |
1 |
0.0002 |
| 479 |
HYDROCEPHALUS |
1 |
0.0002 |
| 480 |
CONSTIPATION |
40 |
0.0002 |
| 481 |
WOUND INFECTION |
2 |
0.0002 |
| 482 |
FAECALOMA |
1 |
0.0002 |
| 483 |
ASTHENOPIA |
1 |
0.0002 |
| 484 |
GASTROINTESTINAL PAIN |
2 |
0.0002 |
| 485 |
DRUG LEVEL INCREASED |
3 |
0.0002 |
| 486 |
PSYCHOMOTOR HYPERACTIVITY |
3 |
0.0002 |
| 487 |
PRODUCT PHYSICAL CONSISTENCY ISSUE |
1 |
0.0002 |
| 488 |
URINARY RETENTION |
6 |
0.0002 |
| 489 |
RASH MACULO-PAPULAR |
4 |
0.0002 |
| 490 |
THROAT IRRITATION |
8 |
0.0002 |
| 491 |
CHROMATURIA |
4 |
0.0002 |
| 492 |
HEMIPARESIS |
3 |
0.0002 |
| 493 |
STATUS EPILEPTICUS |
2 |
0.0002 |
| 494 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
5 |
0.0002 |
| 495 |
DRUG INTERACTION |
28 |
0.0002 |
| 496 |
CHOLECYSTITIS ACUTE |
1 |
0.0002 |
| 497 |
MYOCARDIAL ISCHAEMIA |
2 |
0.0002 |
| 498 |
PARANOIA |
3 |
0.0002 |
| 499 |
DECREASED APPETITE |
40 |
0.0002 |
| 500 |
PERIPHERAL SENSORY NEUROPATHY |
1 |
0.0002 |
| 501 |
ENERGY INCREASED |
1 |
0.0002 |
| 502 |
BRADYKINESIA |
1 |
0.0002 |
| 503 |
AMNESIA |
11 |
0.0002 |
| 504 |
ATAXIA |
2 |
0.0002 |
| 505 |
PLEURISY |
1 |
0.0002 |
| 506 |
CARDIAC PACEMAKER INSERTION |
1 |
0.0002 |
| 507 |
CARDIO-RESPIRATORY ARREST |
7 |
0.0002 |
| 508 |
HEPATITIS CHOLESTATIC |
1 |
0.0002 |
| 509 |
LEUKOCYTOSIS |
3 |
0.0002 |
| 510 |
APHASIA |
5 |
0.0002 |
| 511 |
RESTLESS LEGS SYNDROME |
3 |
0.0002 |
| 512 |
FOETAL GROWTH RESTRICTION |
1 |
0.0002 |
| 513 |
PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
1 |
0.0002 |
| 514 |
CONDITION AGGRAVATED |
49 |
0.0002 |
| 515 |
OLIGURIA |
1 |
0.0002 |
| 516 |
PNEUMONIA |
52 |
0.0002 |
| 517 |
EPSTEIN-BARR VIRUS INFECTION |
1 |
0.0002 |
| 518 |
BLOOD SODIUM DECREASED |
3 |
0.0002 |
| 519 |
SOMNOLENCE |
32 |
0.0002 |
| 520 |
INFUSION SITE SWELLING |
1 |
0.0002 |
| 521 |
DIZZINESS |
79 |
0.0002 |
| 522 |
PHOTOPSIA |
1 |
0.0002 |
| 523 |
DYSPNOEA |
89 |
0.0002 |
| 524 |
PULMONARY FIBROSIS |
3 |
0.0002 |
| 525 |
HEPATITIS |
4 |
0.0002 |
| 526 |
ENTERITIS |
1 |
0.0002 |
| 527 |
ERUCTATION |
3 |
0.0002 |
| 528 |
WEIGHT DECREASED |
43 |
0.0002 |
| 529 |
FALL |
51 |
0.0002 |
| 530 |
MOBILITY DECREASED |
11 |
0.0002 |
| 531 |
SUICIDAL IDEATION |
14 |
0.0002 |
| 532 |
BEDRIDDEN |
2 |
0.0002 |
| 533 |
ORAL CANDIDIASIS |
2 |
0.0002 |
| 534 |
PULMONARY CONGESTION |
2 |
0.0002 |
| 535 |
STAPHYLOCOCCAL INFECTION |
5 |
0.0002 |
| 536 |
ABDOMINAL PAIN |
35 |
0.0002 |
| 537 |
SKIN DISORDER |
5 |
0.0001 |
| 538 |
GAIT INABILITY |
5 |
0.0001 |
| 539 |
LEFT VENTRICULAR DYSFUNCTION |
1 |
0.0001 |
| 540 |
PRODUCT ADMINISTRATION ERROR |
3 |
0.0001 |
| 541 |
MUSCLE SPASMS |
27 |
0.0001 |
| 542 |
MATERNAL EXPOSURE BEFORE PREGNANCY |
1 |
0.0001 |
| 543 |
TACHYCARDIA |
13 |
0.0001 |
| 544 |
BLOOD TESTOSTERONE DECREASED |
1 |
0.0001 |
| 545 |
ECCHYMOSIS |
1 |
0.0001 |
| 546 |
ONYCHOCLASIS |
1 |
0.0001 |
| 547 |
RHABDOMYOLYSIS |
6 |
0.0001 |
| 548 |
POLLAKIURIA |
6 |
0.0001 |
| 549 |
HYPERTRANSAMINASAEMIA |
1 |
0.0001 |
| 550 |
ATRIAL FIBRILLATION |
14 |
0.0001 |
| 551 |
FEELING COLD |
4 |
0.0001 |
| 552 |
DEFAECATION URGENCY |
1 |
0.0001 |
| 553 |
APPLICATION SITE REACTION |
1 |
0.0001 |
| 554 |
SKIN REACTION |
2 |
0.0001 |
| 555 |
LYMPHOPENIA |
2 |
0.0001 |
| 556 |
EATING DISORDER |
3 |
0.0001 |
| 557 |
FEAR OF INJECTION |
1 |
0.0001 |
| 558 |
THERAPY INTERRUPTED |
10 |
0.0001 |
| 559 |
AGGRESSION |
7 |
0.0001 |
| 560 |
PARALYSIS |
2 |
0.0001 |
| 561 |
HYPERSOMNIA |
4 |
0.0001 |
| 562 |
IMPAIRED QUALITY OF LIFE |
2 |
0.0001 |
| 563 |
LETHARGY |
8 |
0.0001 |
| 564 |
DEEP VEIN THROMBOSIS |
9 |
0.0001 |
| 565 |
FAECES DISCOLOURED |
3 |
0.0001 |
| 566 |
COMPLICATION ASSOCIATED WITH DEVICE |
2 |
0.0001 |
| 567 |
FAECES SOFT |
1 |
0.0001 |
| 568 |
NASAL CONGESTION |
8 |
0.0001 |
| 569 |
PSYCHIATRIC SYMPTOM |
1 |
0.0001 |
| 570 |
BLOOD PRESSURE DECREASED |
9 |
0.0001 |
| 571 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
3 |
0.0001 |
| 572 |
LIVER DISORDER |
6 |
0.0001 |
| 573 |
ARTHROPOD BITE |
1 |
0.0001 |
| 574 |
FEELING DRUNK |
1 |
0.0001 |
| 575 |
SEPSIS |
15 |
0.0001 |
| 576 |
PULMONARY MASS |
2 |
0.0001 |
| 577 |
KETOACIDOSIS |
1 |
0.0001 |
| 578 |
PRODUCT AVAILABILITY ISSUE |
3 |
0.0001 |
| 579 |
DEVICE FAILURE |
2 |
0.0001 |
| 580 |
BOWEL MOVEMENT IRREGULARITY |
1 |
0.0001 |
| 581 |
DEVICE PHYSICAL PROPERTY ISSUE |
1 |
0.0001 |
| 582 |
DISSOCIATION |
1 |
0.0001 |
| 583 |
PROCEDURAL COMPLICATION |
1 |
0.0001 |
| 584 |
PHARYNGEAL OEDEMA |
2 |
0.0001 |
| 585 |
PERIPHERAL SWELLING |
20 |
0.0001 |
| 586 |
GENERAL PHYSICAL HEALTH DETERIORATION |
15 |
0.0001 |
| 587 |
HAEMOLYSIS |
1 |
0.0001 |
| 588 |
URINARY TRACT INFECTION |
22 |
0.0001 |
| 589 |
HYPOALBUMINAEMIA |
1 |
0.0001 |
| 590 |
APNOEA |
1 |
0.0001 |
| 591 |
SWOLLEN TONGUE |
4 |
0.0001 |
| 592 |
DRUG SCREEN POSITIVE |
1 |
0.0001 |
| 593 |
NASAL DISCOMFORT |
1 |
0.0001 |
| 594 |
PRODUCTIVE COUGH |
6 |
0.0001 |
| 595 |
GINGIVAL PAIN |
1 |
0.0001 |
| 596 |
ABSCESS |
2 |
0.0001 |
| 597 |
ATRIAL FLUTTER |
1 |
0.0001 |
| 598 |
DIABETIC KETOACIDOSIS |
3 |
0.0001 |
| 599 |
ABDOMINAL DISTENSION |
13 |
0.0001 |
| 600 |
LIVER INJURY |
3 |
0.0001 |
| 601 |
DYSPEPSIA |
12 |
0.0001 |
| 602 |
HICCUPS |
1 |
0.0001 |
| 603 |
HYPERAESTHESIA |
1 |
0.0001 |
| 604 |
AGEUSIA |
3 |
0.0001 |
| 605 |
LIP SWELLING |
4 |
0.0001 |
| 606 |
WITHDRAWAL SYNDROME |
5 |
0.0001 |
| 607 |
INFUSION SITE ERYTHEMA |
1 |
0.0001 |
| 608 |
FATIGUE |
92 |
0.0001 |
| 609 |
PRODUCT USE ISSUE |
22 |
0.0001 |
| 610 |
FEELING ABNORMAL |
28 |
0.0001 |
| 611 |
PRODUCT CONTAINER ISSUE |
1 |
0.0001 |
| 612 |
PSEUDOMONAS INFECTION |
1 |
0.0001 |
| 613 |
RASH GENERALISED |
3 |
0.0001 |
| 614 |
PLEURAL EFFUSION |
7 |
0.0001 |
| 615 |
SEPTIC SHOCK |
5 |
0.0001 |
| 616 |
MUSCULOSKELETAL PAIN |
6 |
0.0001 |
| 617 |
PARAESTHESIA |
18 |
0.0001 |
| 618 |
NEUROTOXICITY |
2 |
0.0001 |
| 619 |
LYMPHOCYTE COUNT DECREASED |
2 |
0.0001 |
| 620 |
BLOOD BILIRUBIN INCREASED |
3 |
0.0001 |
| 621 |
HEART RATE INCREASED |
11 |
0.0001 |
| 622 |
DRY MOUTH |
9 |
0.0001 |
| 623 |
TOOTHACHE |
2 |
0.0001 |
| 624 |
OPTIC NEURITIS |
1 |
0.0001 |
| 625 |
PANIC ATTACK |
4 |
0.0001 |
| 626 |
INTENTIONAL OVERDOSE |
7 |
0.0001 |
| 627 |
INCREASED TENDENCY TO BRUISE |
1 |
0.0001 |
| 628 |
PERSONALITY CHANGE |
1 |
0.0001 |
| 629 |
HEPATIC STEATOSIS |
2 |
0.0001 |
| 630 |
PANCYTOPENIA |
6 |
0.0001 |
| 631 |
APPENDICITIS |
1 |
0.0001 |
| 632 |
DIARRHOEA HAEMORRHAGIC |
1 |
0.0001 |
| 633 |
COUGH |
30 |
0.0001 |
| 634 |
ILLNESS |
11 |
0.0001 |
| 635 |
VOMITING |
50 |
0.0001 |
| 636 |
DYSPNOEA EXERTIONAL |
4 |
0.0001 |
| 637 |
MUSCULOSKELETAL DISORDER |
2 |
0.0001 |
| 638 |
COMA |
5 |
0.0001 |
| 639 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
3 |
0.0001 |
| 640 |
AFFECT LABILITY |
1 |
0.0001 |
| 641 |
PRESCRIBED OVERDOSE |
2 |
0.0001 |
| 642 |
DYSSTASIA |
3 |
0.0001 |
| 643 |
MUSCULOSKELETAL STIFFNESS |
9 |
0.0001 |
| 644 |
AUTOIMMUNE DISORDER |
1 |
0.0001 |
| 645 |
DRUG WITHDRAWAL SYNDROME |
9 |
0.0001 |
| 646 |
PHARYNGEAL SWELLING |
1 |
0.0001 |
| 647 |
LUNG DISORDER |
5 |
0.0001 |
| 648 |
HEPATOMEGALY |
1 |
0.0001 |
| 649 |
LIGAMENT SPRAIN |
1 |
0.0001 |
| 650 |
INABILITY TO AFFORD MEDICATION |
1 |
0.0001 |
| 651 |
HYPOTONIA |
1 |
0.0001 |
| 652 |
DRY THROAT |
1 |
0.0001 |
| 653 |
BLOOD PRESSURE INCREASED |
15 |
0.0001 |
| 654 |
EAR DISCOMFORT |
1 |
0.0001 |
| 655 |
DRUG-INDUCED LIVER INJURY |
3 |
0.0001 |
| 656 |
PRODUCT ODOUR ABNORMAL |
1 |
0.0001 |
| 657 |
FULL BLOOD COUNT ABNORMAL |
1 |
0.0001 |
| 658 |
CYSTITIS |
3 |
0.0001 |
| 659 |
HEADACHE |
59 |
0.0001 |
| 660 |
BREAST PAIN |
1 |
0.0001 |
| 661 |
MALAISE |
41 |
0.0001 |
| 662 |
HEREDITARY ANGIOEDEMA |
1 |
0.0001 |
| 663 |
DRUG INTOLERANCE |
9 |
0.0001 |
| 664 |
ALTERED STATE OF CONSCIOUSNESS |
2 |
0.0001 |
| 665 |
RASH PRURITIC |
5 |
0.0001 |
| 666 |
BIPOLAR DISORDER |
1 |
0.0001 |
| 667 |
BACK INJURY |
1 |
0.0001 |
| 668 |
PRODUCT PRESCRIBING ISSUE |
2 |
0.0001 |
| 669 |
ALOPECIA |
18 |
0.0001 |
| 670 |
CLOSTRIDIUM DIFFICILE INFECTION |
2 |
0.0001 |
| 671 |
OESOPHAGITIS |
1 |
0.0001 |
| 672 |
INTERVERTEBRAL DISC PROTRUSION |
2 |
0.0001 |
| 673 |
BLOOD GLUCOSE FLUCTUATION |
1 |
0.0001 |
| 674 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
5 |
0.0001 |
| 675 |
FOOT DEFORMITY |
1 |
0.0001 |
| 676 |
DEHYDRATION |
12 |
0.0001 |
| 677 |
OBSTRUCTIVE AIRWAYS DISORDER |
1 |
0.0001 |
| 678 |
HYPERTENSIVE CRISIS |
1 |
0.0001 |
| 679 |
HEPATOTOXICITY |
2 |
0.0001 |
| 680 |
ORAL PAIN |
2 |
0.0001 |
| 681 |
SNEEZING |
2 |
0.0001 |
| 682 |
OCULAR DISCOMFORT |
1 |
0.0001 |
| 683 |
TRANSIENT ISCHAEMIC ATTACK |
3 |
0.0001 |
| 684 |
EYE INFECTION |
1 |
0.0001 |
| 685 |
IMPAIRED DRIVING ABILITY |
1 |
0.0001 |
| 686 |
DERMATITIS CONTACT |
1 |
0.0001 |
| 687 |
NEPHROLITHIASIS |
4 |
0.0001 |
| 688 |
TINNITUS |
4 |
0.0001 |
| 689 |
NIGHTMARE |
3 |
0.0001 |
| 690 |
HYPOKALAEMIA |
4 |
0.0001 |
| 691 |
DELIRIUM |
3 |
0.0001 |
| 692 |
HYPERSENSITIVITY |
16 |
0.0001 |
| 693 |
ELECTROLYTE IMBALANCE |
1 |
0.0001 |
| 694 |
LOSS OF CONSCIOUSNESS |
11 |
0.0001 |
| 695 |
COGNITIVE DISORDER |
4 |
0.0001 |
| 696 |
HEART RATE DECREASED |
3 |
0.0001 |
| 697 |
HYPERHIDROSIS |
11 |
0.0001 |
| 698 |
CHILLS |
10 |
0.0001 |
| 699 |
INFLUENZA LIKE ILLNESS |
7 |
0.0001 |
| 700 |
HOSPITALISATION |
13 |
0.0001 |
| 701 |
TREMOR |
14 |
0.0001 |
| 702 |
NEUROLEPTIC MALIGNANT SYNDROME |
1 |
0.0001 |
| 703 |
BACTERAEMIA |
1 |
0.0001 |
| 704 |
PRODUCT PRESCRIBING ERROR |
2 |
0.0001 |
| 705 |
CHOLECYSTITIS |
1 |
0.0001 |
| 706 |
MYOCLONUS |
1 |
0.0001 |
| 707 |
BLOOD GLUCOSE DECREASED |
4 |
0.0001 |
| 708 |
SKIN EXFOLIATION |
7 |
0.0001 |
| 709 |
DRUG EFFECT INCOMPLETE |
3 |
0.0001 |
| 710 |
VERTIGO |
5 |
0.0001 |
| 711 |
NO THERAPEUTIC RESPONSE |
1 |
0.0001 |
| 712 |
PRODUCT DOSE OMISSION ISSUE |
24 |
0.0001 |
| 713 |
HYPERCALCAEMIA |
1 |
0.0001 |
| 714 |
ANXIETY |
23 |
0.0001 |
| 715 |
PRURITUS |
31 |
0.0001 |
| 716 |
PHARYNGITIS |
1 |
0.0001 |
| 717 |
INTESTINAL OBSTRUCTION |
3 |
0.0001 |
| 718 |
WHITE BLOOD CELL COUNT INCREASED |
3 |
0.0001 |
| 719 |
ANOREXIA |
1 |
0.0001 |
| 720 |
RHINORRHOEA |
5 |
0.0001 |
| 721 |
HAEMATOMA |
2 |
0.0001 |
| 722 |
DIPLOPIA |
2 |
0.0001 |
| 723 |
PLATELET COUNT INCREASED |
1 |
0.0001 |
| 724 |
DRUG INEFFECTIVE |
101 |
0.0001 |
| 725 |
PRODUCT DOSE OMISSION |
5 |
0.0001 |
| 726 |
SEDATION |
2 |
0.0001 |
| 727 |
JOINT STIFFNESS |
2 |
0.0001 |
| 728 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
3 |
0.0001 |
| 729 |
ABNORMAL BEHAVIOUR |
3 |
0.0001 |
| 730 |
BRADYCARDIA |
4 |
0.0001 |
| 731 |
ADVERSE REACTION |
1 |
0.0001 |
| 732 |
FEAR |
2 |
0.0001 |
| 733 |
OFF LABEL USE |
65 |
0.0001 |
| 734 |
EXTRA DOSE ADMINISTERED |
3 |
0.0001 |
| 735 |
FREQUENT BOWEL MOVEMENTS |
2 |
0.0001 |
| 736 |
DYSKINESIA |
3 |
0.0001 |
| 737 |
OEDEMA |
4 |
0.0001 |
| 738 |
NEUTROPENIA |
10 |
0.0001 |
| 739 |
HYPOAESTHESIA |
11 |
0.0001 |
| 740 |
DRUG TOXICITY |
1 |
0.0001 |
| 741 |
IMPAIRED GASTRIC EMPTYING |
1 |
0.0001 |
| 742 |
PERIPHERAL COLDNESS |
1 |
0.0001 |
| 743 |
CARDIAC ARREST |
6 |
0.0001 |
| 744 |
RESPIRATORY ARREST |
2 |
0.0001 |
| 745 |
MENTAL STATUS CHANGES |
2 |
0.0001 |
| 746 |
COMPLETED SUICIDE |
6 |
0.0001 |
| 747 |
HYPOMAGNESAEMIA |
1 |
0.0001 |
| 748 |
NECK PAIN |
4 |
0.0001 |
| 749 |
CARPAL TUNNEL SYNDROME |
1 |
0.0001 |
| 750 |
INSOMNIA |
19 |
0.0001 |
| 751 |
BURNING SENSATION |
5 |
0.0001 |
| 752 |
BLOOD TEST ABNORMAL |
1 |
0.0001 |
| 753 |
INCORRECT DRUG ADMINISTRATION DURATION |
2 |
0.0001 |
| 754 |
TARDIVE DYSKINESIA |
2 |
0.0001 |
| 755 |
INTERNATIONAL NORMALISED RATIO INCREASED |
2 |
0.0001 |
| 756 |
BRONCHOSPASM |
1 |
0.0001 |
| 757 |
RED BLOOD CELL COUNT DECREASED |
2 |
0.0001 |
| 758 |
PANCREATIC CARCINOMA |
2 |
0.0001 |
| 759 |
ANOSMIA |
1 |
0.0001 |
| 760 |
HYPERTHYROIDISM |
1 |
0.0001 |
| 761 |
LIVER FUNCTION TEST ABNORMAL |
2 |
0.0001 |
| 762 |
APATHY |
1 |
0.0001 |
| 763 |
CHEST DISCOMFORT |
7 |
0.0001 |
| 764 |
AGITATION |
5 |
0.0001 |
| 765 |
BRONCHITIS |
5 |
0.0001 |
| 766 |
URINARY INCONTINENCE |
2 |
0.0001 |
| 767 |
THERAPY NON-RESPONDER |
3 |
0.0001 |
| 768 |
BLOOD POTASSIUM DECREASED |
2 |
0.0001 |
| 769 |
PYREXIA |
23 |
0.0001 |
| 770 |
UNEVALUABLE EVENT |
5 |
0.0001 |
| 771 |
SUICIDE ATTEMPT |
4 |
0.0001 |
| 772 |
BLOOD COUNT ABNORMAL |
1 |
0.0001 |
| 773 |
DEPRESSION |
15 |
0.0001 |
| 774 |
EPILEPSY |
2 |
0.0001 |
| 775 |
SKIN DISCOLOURATION |
3 |
0.0001 |
| 776 |
MYALGIA |
11 |
0.0001 |
| 777 |
ANKLE FRACTURE |
1 |
0.0001 |
| 778 |
RASH |
28 |
0.0001 |
| 779 |
BRAIN FOG |
1 |
0.0001 |
| 780 |
ARRHYTHMIA |
3 |
0.0001 |
| 781 |
HALLUCINATION, AUDITORY |
1 |
0.0001 |
| 782 |
INFLUENZA |
7 |
0.0001 |
| 783 |
MOVEMENT DISORDER |
2 |
0.0001 |
| 784 |
MUSCLE TIGHTNESS |
1 |
0.0001 |
| 785 |
BACK DISORDER |
1 |
0.0001 |
| 786 |
CHOLELITHIASIS |
2 |
0.0001 |
| 787 |
EYE DISORDER |
2 |
0.0001 |
| 788 |
MANIA |
1 |
0.0001 |
| 789 |
TREATMENT FAILURE |
5 |
0.0001 |
| 790 |
VISUAL ACUITY REDUCED |
2 |
0.0001 |
| 791 |
COAGULOPATHY |
1 |
0.0001 |
| 792 |
BLOOD UREA INCREASED |
1 |
0.0001 |
| 793 |
PERICARDITIS |
1 |
0.0001 |
| 794 |
MUSCULOSKELETAL DISCOMFORT |
1 |
0.0001 |
| 795 |
JOINT SWELLING |
7 |
0.0001 |
| 796 |
PAIN IN EXTREMITY |
17 |
0.0001 |
| 797 |
INTENTIONAL PRODUCT MISUSE |
5 |
0.0001 |
| 798 |
AMENORRHOEA |
1 |
0.0001 |
| 799 |
COVID-19 |
10 |
0.0001 |
| 800 |
HYPERTENSION |
12 |
0.0001 |
| 801 |
LYMPHADENOPATHY |
2 |
0.0001 |
| 802 |
HEAD DISCOMFORT |
1 |
0.0001 |
| 803 |
BACK PAIN |
13 |
0.0001 |
| 804 |
GOUT |
1 |
0.0001 |
| 805 |
CONFUSIONAL STATE |
9 |
0.0001 |
| 806 |
ELECTROCARDIOGRAM QT PROLONGED |
2 |
0.0001 |
| 807 |
GASTROENTERITIS VIRAL |
1 |
0.0001 |
| 808 |
PELVIC PAIN |
1 |
0.0001 |
| 809 |
C-REACTIVE PROTEIN INCREASED |
2 |
0.0001 |
| 810 |
HYPOTENSION |
11 |
0.0001 |
| 811 |
DYSURIA |
2 |
0.0001 |
| 812 |
DYSGEUSIA |
4 |
0.0001 |
| 813 |
BACTERIAL INFECTION |
1 |
0.0001 |
| 814 |
MIDDLE INSOMNIA |
1 |
0.0001 |
| 815 |
ACNE |
4 |
0.0001 |
| 816 |
FOOT FRACTURE |
1 |
0.0001 |
| 817 |
BLOOD URINE PRESENT |
1 |
0.0001 |
| 818 |
PROTEINURIA |
1 |
0.0001 |
| 819 |
DIABETES MELLITUS |
4 |
0.0001 |
| 820 |
DRY SKIN |
7 |
0.0001 |
| 821 |
EYE IRRITATION |
3 |
0.0001 |
| 822 |
DRUG PRESCRIBING ERROR |
1 |
0.0001 |
| 823 |
SEIZURE |
6 |
0.0001 |
| 824 |
DYSTONIA |
1 |
0.0001 |
| 825 |
WHEEZING |
3 |
0.0001 |
| 826 |
ACTIVITIES OF DAILY LIVING IMPAIRED |
1 |
0.0001 |
| 827 |
DISORIENTATION |
2 |
0.0001 |
| 828 |
HAEMATOCRIT DECREASED |
1 |
0.0001 |
| 829 |
COMPLICATION OF DEVICE INSERTION |
1 |
0.0001 |
| 830 |
PRESCRIBED UNDERDOSE |
1 |
0.0001 |
| 831 |
GASTROOESOPHAGEAL REFLUX DISEASE |
4 |
0.0000 |
| 832 |
STOMATITIS |
3 |
0.0000 |
| 833 |
FEEDING DISORDER |
1 |
0.0000 |
| 834 |
OEDEMA PERIPHERAL |
6 |
0.0000 |
| 835 |
FLUSHING |
5 |
0.0000 |
| 836 |
DISCOMFORT |
3 |
0.0000 |
| 837 |
NEUTROPHIL COUNT DECREASED |
2 |
0.0000 |
| 838 |
BODY TEMPERATURE INCREASED |
1 |
0.0000 |
| 839 |
PRODUCT PREPARATION ERROR |
1 |
0.0000 |
| 840 |
DERMATITIS |
1 |
0.0000 |
| 841 |
KNEE ARTHROPLASTY |
1 |
0.0000 |
| 842 |
TOXICITY TO VARIOUS AGENTS |
8 |
0.0000 |
| 843 |
HALLUCINATION, VISUAL |
1 |
0.0000 |
| 844 |
ANAEMIA |
9 |
0.0000 |
| 845 |
OSTEOARTHRITIS |
2 |
0.0000 |
| 846 |
JOINT INJURY |
1 |
0.0000 |
| 847 |
IMPAIRED WORK ABILITY |
1 |
0.0000 |
| 848 |
HYPOACUSIS |
2 |
0.0000 |
| 849 |
DEVICE DISLOCATION |
2 |
0.0000 |
| 850 |
ACUTE KIDNEY INJURY |
7 |
0.0000 |
| 851 |
MELAENA |
1 |
0.0000 |
| 852 |
FEBRILE NEUTROPENIA |
3 |
0.0000 |
| 853 |
THROMBOCYTOPENIA |
5 |
0.0000 |
| 854 |
GLOSSODYNIA |
1 |
0.0000 |
| 855 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
9 |
0.0000 |
| 856 |
UPPER RESPIRATORY TRACT INFECTION |
2 |
0.0000 |
| 857 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
3 |
0.0000 |
| 858 |
URTICARIA |
7 |
0.0000 |
| 859 |
BLOOD PRESSURE FLUCTUATION |
1 |
0.0000 |
| 860 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
2 |
0.0000 |
| 861 |
HEPATIC CANCER |
1 |
0.0000 |
| 862 |
PRESYNCOPE |
1 |
0.0000 |
| 863 |
NEURALGIA |
1 |
0.0000 |
| 864 |
CEREBRAL INFARCTION |
1 |
0.0000 |
| 865 |
ABASIA |
1 |
0.0000 |
| 866 |
HOT FLUSH |
3 |
0.0000 |
| 867 |
CELLULITIS |
2 |
0.0000 |
| 868 |
GLYCOSYLATED HAEMOGLOBIN INCREASED |
1 |
0.0000 |
| 869 |
GASTRIC CANCER |
1 |
0.0000 |
| 870 |
PRODUCT COMPLAINT |
1 |
0.0000 |
| 871 |
HAEMATEMESIS |
1 |
0.0000 |
| 872 |
CARDIOVASCULAR DISORDER |
1 |
0.0000 |
| 873 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
7 |
0.0000 |
| 874 |
INFLAMMATION |
2 |
0.0000 |
| 875 |
NO ADVERSE EVENT |
7 |
0.0000 |
| 876 |
ECZEMA |
2 |
0.0000 |
| 877 |
GASTRITIS |
1 |
0.0000 |
| 878 |
NASOPHARYNGITIS |
7 |
0.0000 |
| 879 |
EAR INFECTION |
1 |
0.0000 |
| 880 |
BREAST CANCER FEMALE |
1 |
0.0000 |
| 881 |
CARDIAC FAILURE CONGESTIVE |
3 |
0.0000 |
| 882 |
THROMBOSIS |
3 |
0.0000 |
| 883 |
DISTURBANCE IN ATTENTION |
2 |
0.0000 |
| 884 |
WHITE BLOOD CELL COUNT DECREASED |
4 |
0.0000 |
| 885 |
LIMB INJURY |
1 |
0.0000 |
| 886 |
MEMORY IMPAIRMENT |
5 |
0.0000 |
| 887 |
PRODUCT USE IN UNAPPROVED INDICATION |
9 |
0.0000 |
| 888 |
ABNORMAL DREAMS |
1 |
0.0000 |
| 889 |
ANAPHYLACTIC REACTION |
2 |
0.0000 |
| 890 |
PROCEDURAL PAIN |
1 |
0.0000 |
| 891 |
MEDICATION ERROR |
2 |
0.0000 |
| 892 |
GASTROINTESTINAL HAEMORRHAGE |
3 |
0.0000 |
| 893 |
WEIGHT INCREASED |
8 |
0.0000 |
| 894 |
RENAL IMPAIRMENT |
3 |
0.0000 |
| 895 |
BLISTER |
2 |
0.0000 |
| 896 |
EYE PAIN |
2 |
0.0000 |
| 897 |
PRODUCT DOSE OMISSION IN ERROR |
1 |
0.0000 |
| 898 |
INCORRECT DOSE ADMINISTERED |
8 |
0.0000 |
| 899 |
PRODUCT SUBSTITUTION ISSUE |
2 |
0.0000 |
| 900 |
PRODUCT STORAGE ERROR |
3 |
0.0000 |
| 901 |
ACUTE MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 902 |
LABORATORY TEST ABNORMAL |
1 |
0.0000 |
| 903 |
CATARACT |
2 |
0.0000 |
| 904 |
DEVICE ISSUE |
3 |
0.0000 |
| 905 |
HEPATIC FAILURE |
1 |
0.0000 |
| 906 |
LACRIMATION INCREASED |
1 |
0.0000 |
| 907 |
CONTRAINDICATED PRODUCT ADMINISTERED |
1 |
0.0000 |
| 908 |
CORONARY ARTERY DISEASE |
1 |
0.0000 |
| 909 |
THERAPEUTIC RESPONSE DECREASED |
2 |
0.0000 |
| 910 |
ILL-DEFINED DISORDER |
2 |
0.0000 |
| 911 |
INJECTION SITE RASH |
1 |
0.0000 |
| 912 |
ADVERSE EVENT |
3 |
0.0000 |
| 913 |
NERVOUS SYSTEM DISORDER |
1 |
0.0000 |
| 914 |
MOOD SWINGS |
1 |
0.0000 |
| 915 |
METABOLIC ACIDOSIS |
1 |
0.0000 |
| 916 |
HIP FRACTURE |
1 |
0.0000 |
| 917 |
PAIN |
19 |
0.0000 |
| 918 |
SWELLING FACE |
2 |
0.0000 |
| 919 |
RENAL FAILURE |
4 |
0.0000 |
| 920 |
ANGER |
1 |
0.0000 |
| 921 |
PRODUCT QUALITY ISSUE |
4 |
0.0000 |
| 922 |
DRUG EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 923 |
HAEMOGLOBIN DECREASED |
3 |
0.0000 |
| 924 |
HAEMATURIA |
1 |
0.0000 |
| 925 |
HYPERKALAEMIA |
1 |
0.0000 |
| 926 |
DEVICE MALFUNCTION |
2 |
0.0000 |
| 927 |
INCORRECT ROUTE OF DRUG ADMINISTRATION |
1 |
0.0000 |
| 928 |
CEREBRAL HAEMORRHAGE |
1 |
0.0000 |
| 929 |
SKIN BURNING SENSATION |
2 |
0.0000 |
| 930 |
CRYING |
1 |
0.0000 |
| 931 |
HYPERGLYCAEMIA |
1 |
0.0000 |
| 932 |
ACCIDENTAL OVERDOSE |
1 |
0.0000 |
| 933 |
EYE SWELLING |
1 |
0.0000 |
| 934 |
ASTHMA |
3 |
0.0000 |
| 935 |
HALLUCINATION |
2 |
0.0000 |
| 936 |
COLITIS |
1 |
0.0000 |
| 937 |
CHRONIC KIDNEY DISEASE |
2 |
0.0000 |
| 938 |
PALPITATIONS |
3 |
0.0000 |
| 939 |
ABORTION SPONTANEOUS |
1 |
0.0000 |
| 940 |
BLINDNESS |
1 |
0.0000 |
| 941 |
ERYTHEMA |
5 |
0.0000 |
| 942 |
CEREBROVASCULAR ACCIDENT |
4 |
0.0000 |
| 943 |
MENTAL DISORDER |
1 |
0.0000 |
| 944 |
MYOCARDIAL INFARCTION |
4 |
0.0000 |
| 945 |
INTENTIONAL PRODUCT USE ISSUE |
2 |
0.0000 |
| 946 |
ANGIOEDEMA |
1 |
0.0000 |
| 947 |
CHEST PAIN |
4 |
0.0000 |
| 948 |
BREAST CANCER |
2 |
0.0000 |
| 949 |
BLOOD CHOLESTEROL INCREASED |
1 |
0.0000 |
| 950 |
CARDIAC DISORDER |
2 |
0.0000 |
| 951 |
OCULAR HYPERAEMIA |
1 |
0.0000 |
| 952 |
NEUROPATHY PERIPHERAL |
2 |
0.0000 |
| 953 |
DISEASE RECURRENCE |
1 |
0.0000 |
| 954 |
MULTIPLE SCLEROSIS |
1 |
0.0000 |
| 955 |
HYPOGLYCAEMIA |
1 |
0.0000 |
| 956 |
DRY EYE |
1 |
0.0000 |
| 957 |
LEUKOPENIA |
1 |
0.0000 |
| 958 |
SYNCOPE |
2 |
0.0000 |
| 959 |
FLUID RETENTION |
1 |
0.0000 |
| 960 |
NERVOUSNESS |
1 |
0.0000 |
| 961 |
HAEMORRHAGE |
2 |
0.0000 |
| 962 |
PLATELET COUNT DECREASED |
2 |
0.0000 |
| 963 |
DRUG EFFECT DECREASED |
1 |
0.0000 |
| 964 |
OVERDOSE |
4 |
0.0000 |
| 965 |
HAEMATOCHEZIA |
1 |
0.0000 |
| 966 |
ARTHROPATHY |
1 |
0.0000 |
| 967 |
CONVULSION |
1 |
0.0000 |
| 968 |
HERPES ZOSTER |
1 |
0.0000 |
| 969 |
IRRITABILITY |
1 |
0.0000 |
| 970 |
EMOTIONAL DISTRESS |
2 |
0.0000 |
| 971 |
VISUAL IMPAIRMENT |
2 |
0.0000 |
| 972 |
EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 973 |
DEVICE DIFFICULT TO USE |
1 |
0.0000 |
| 974 |
INFUSION RELATED REACTION |
1 |
0.0000 |
| 975 |
INJECTION SITE PRURITUS |
1 |
0.0000 |
| 976 |
MULTIPLE SCLEROSIS RELAPSE |
1 |
0.0000 |
| 977 |
VISION BLURRED |
2 |
0.0000 |
| 978 |
INFECTION |
2 |
0.0000 |
| 979 |
INJECTION SITE SWELLING |
1 |
0.0000 |
| 980 |
FOETAL EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 981 |
DRUG DOSE OMISSION |
2 |
0.0000 |
| 982 |
ARTHRALGIA |
5 |
0.0000 |
| 983 |
OROPHARYNGEAL PAIN |
1 |
0.0000 |
| 984 |
MIGRAINE |
1 |
0.0000 |
| 985 |
CONTUSION |
1 |
0.0000 |
| 986 |
PSORIASIS |
1 |
0.0000 |
| 987 |
INJECTION SITE PAIN |
2 |
0.0000 |
| 988 |
BLOOD GLUCOSE INCREASED |
1 |
0.0000 |